Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] Benzoate
2. Cholesterylbenzoate
3. 5-cholesten-3.beta.-ol Benzoate
4. Mfcd00003635
5. Cholest-5-en-3-ol (3.beta.)-, Benzoate
6. Chemdiv1_019249
7. Schembl12290962
8. Hms641k21
9. Dtxsid30862274
10. Sy059916
11. Ft-0623756
12. Sr-01000391777
13. Sr-01000391777-1
| Molecular Weight | 490.8 g/mol |
|---|---|
| Molecular Formula | C34H50O2 |
| XLogP3 | 10.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 8 |
| Exact Mass | 490.381080833 g/mol |
| Monoisotopic Mass | 490.381080833 g/mol |
| Topological Polar Surface Area | 26.3 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 806 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 8 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Cholesteryl Benzoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cholesteryl Benzoate, including repackagers and relabelers. The FDA regulates Cholesteryl Benzoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cholesteryl Benzoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cholesteryl Benzoate supplier is an individual or a company that provides Cholesteryl Benzoate active pharmaceutical ingredient (API) or Cholesteryl Benzoate finished formulations upon request. The Cholesteryl Benzoate suppliers may include Cholesteryl Benzoate API manufacturers, exporters, distributors and traders.
click here to find a list of Cholesteryl Benzoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cholesteryl Benzoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Cholesteryl Benzoate active pharmaceutical ingredient (API) in detail. Different forms of Cholesteryl Benzoate DMFs exist exist since differing nations have different regulations, such as Cholesteryl Benzoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cholesteryl Benzoate DMF submitted to regulatory agencies in the US is known as a USDMF. Cholesteryl Benzoate USDMF includes data on Cholesteryl Benzoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cholesteryl Benzoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cholesteryl Benzoate suppliers with USDMF on PharmaCompass.
Cholesteryl Benzoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cholesteryl Benzoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cholesteryl Benzoate GMP manufacturer or Cholesteryl Benzoate GMP API supplier for your needs.
A Cholesteryl Benzoate CoA (Certificate of Analysis) is a formal document that attests to Cholesteryl Benzoate's compliance with Cholesteryl Benzoate specifications and serves as a tool for batch-level quality control.
Cholesteryl Benzoate CoA mostly includes findings from lab analyses of a specific batch. For each Cholesteryl Benzoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cholesteryl Benzoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cholesteryl Benzoate EP), Cholesteryl Benzoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cholesteryl Benzoate USP).
LOOKING FOR A SUPPLIER?
